Hisamitsu Pharmaceutical Co., Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Feb'25
Feb'24
Feb'23
Feb'22
Feb'21
Feb'20
No of Months
12
12
12
12
12
12
Profit Before Tax
28,687.00
19,186.00
16,113.00
12,956.00
12,197.00
26,155.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-7,066.00
-1,314.00
-1,322.00
3,861.00
-3,096.00
-418.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
18,765.00
18,188.00
12,727.00
19,199.00
5,289.00
27,395.00
Cash Flow from Investing Activities
17,563.00
-2,512.00
-23,868.00
-13,060.00
7,815.00
-17,229.00
Cash Flow from Financing Activities
-15,850.00
-16,691.00
-14,687.00
-15,189.00
-7,187.00
-11,726.00
Net Cash Inflow / Outflow
23,414.00
942.00
-20,823.00
-5,106.00
4,358.00
-1,785.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
2,936.00
1,957.00
5,005.00
3,944.00
-1,559.00
-225.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Hisamitsu Pharmaceutical Co., Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
28687
47442
-18,755.00
-39.53%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-7066
-12787
5,721.00
44.74%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
18765
43500
-24,735.00
-56.86%
Cash Flow from Investing Activities
17563
-12974
30,537.00
235.37%
Cash Flow from Financing Activities
-15850
-49348
33,498.00
67.88%
Net Cash Inflow / Outflow
23414
-12122
35,536.00
293.15%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
2936
6700
-3,764.00
-56.18%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Feb'25
YoY Growth in year ended Feb 2025 is 3.17% vs 42.91% in Feb 2024
Feb'25
Feb'24
Change(%)
Cash Flow from Operating Activities
18,765.00
18,188.00
3.17%






